JOHNSON DAVID LEE
SEC CIK 1733883 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VERA | Vera Therapeutics, Inc. | COO | 45.7K | — | $108.3K | 3 | 2025-02-18 | 2026-02-23 |
Most active insiders at VERA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Fordyce Marshall | Pres AND CEO, Dir | — | $9.73M |
| 2 | Turner William D. | Chief Regulatory Off | — | $1.45M |
| 3 | Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | — | $566.8K |
| 4 | ENRIGHT PATRICK G | Dir | $250.0K | — |
| 5 | Grant Sean | CFO | — | $207.8K |
| 6 | JOHNSON DAVID LEE | COO | — | $108.3K |
| 7 | Carter Jason S | CLO | — | $107.5K |
| 8 | Brenner Robert | Chief Medical Off | — | $90.3K |
| 9 | Skelton Laurence Matthew | Chief Commercial Off | — | $66.4K |
| 10 | Boman Nancy Lee | Chief Regulatory Off | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-25 | 2026-02-23 | VERA | Vera Therapeutics, Inc. | JOHNSON DAVID LEE | COO | S - Sale | $41.98 | -2,579 | 45.7K | -5% | -$108.3K | |
| D | 2026-02-06 | 2026-02-04 | VERA | Vera Therapeutics, Inc. | JOHNSON DAVID LEE | COO | A - Grant | $0.00 | +20.0K | 48.3K | +71% | $0 |
| D | 2025-02-20 | 2025-02-18 | VERA | Vera Therapeutics, Inc. | JOHNSON DAVID LEE | COO | A - Grant | $0.00 | +26.9K | 26.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations